SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001130319-08-000461
Filing Date
2008-05-27
Accepted
2008-05-27 10:38:52
Documents
1
Period of Report
2008-05-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K o40788e8vk.htm 8-K 66950
  Complete submission text file 0001130319-08-000461.txt   68564
Mailing Address 50 AUDUBON ROAD SUITE B WAKEFIELD MA 01880
Business Address 50 AUDUBON ROAD SUITE B WAKEFIELD MA 01880 781-224-1444
NUCRYST Pharmaceuticals Corp. (Filer) CIK: 0001344674 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51686 | Film No.: 08859693
SIC: 3841 Surgical & Medical Instruments & Apparatus
Assistant Director 10